Repair what is lost: Neuroprotection through neural stem cells in progressive MS

por Schoonheim, Menno M., Strijbis, Eva M.M.
Publicado 2023

4-aminopyridine is not just a symptomatic therapy, it has a neuroprotective effect – Yes

por Strijbis, Eva MM, Nij Bijvank, Jenny A, Killestein, Joep
Publicado 2020

Disease severity classification using passively collected smartphone-based keystroke dynamics within multiple sclerosis

por Hoeijmakers, Aleide, Licitra, Giovanni, Meijer, Kim, Lam, Ka-Hoo, Molenaar, Pam, Strijbis, Eva, Killestein, Joep
Publicado 2023

Is MS affecting the CNS only?: Lessons from clinic to myelin pathophysiology

por Oudejans, Ellen, Luchicchi, Antonio, Strijbis, Eva M.M., Geurts, Jeroen J.G., van Dam, Anne-Marie
Publicado 2020

MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis

por Koch, Marcus W, Mostert, Jop, Repovic, Pavle, Bowen, James D, Strijbis, Eva, Uitdehaag, Bernard, Cutter, Gary
Publicado 2021

Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS

por W Koch, Marcus, Mostert, Jop, Repovic, Pavle, Bowen, James D, Strijbis, Eva, Uitdehaag, Bernard, Cutter, Gary
Publicado 2021

The Potential Impact of Digital Biomarkers in Multiple Sclerosis in The Netherlands: An Early Health Technology Assessment of MS Sherpa

por Cloosterman, Sonja, Wijnands, Inez, Huygens, Simone, Wester, Valérie, Lam, Ka-Hoo, Strijbis, Eva, den Teuling, Bram, Versteegh, Matthijs
Publicado 2021

The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials

por Strijbis, Eva MM, Repovic, Pavle, Mostert, Jop, Bowen, James D, Uitdehaag, Bernard MJ, Cutter, Gary, Koch, Marcus W
Publicado 2022

Personalized monitoring of ambulatory function with a smartphone 2-minute walk test in multiple sclerosis

por Lam, Ka-Hoo, Bucur, Ioan Gabriel, van Oirschot, Pim, de Graaf, Frank, Strijbis, Eva, Uitdehaag, Bernard, Heskes, Tom, Killestein, Joep, de Groot, Vincent
Publicado 2023

The role of diet in multiple sclerosis onset and course: results from a nationwide retrospective birth‐year cohort

por Loonstra, Floor C., de Ruiter, Lodewijk R. J., Schoonheim, Menno M., Moraal, Bastiaan, Strijbis, Eva M. M., de Jong, Brigit A., Uitdehaag, Bernard M. J.
Publicado 2023

Myelin Quantification in White Matter Pathology of Progressive Multiple Sclerosis Post-Mortem Brain Samples: A New Approach for Quantifying Remyelination

por Huitema, Marije J. D., Strijbis, Eva M. M., Luchicchi, Antonio, Bol, John G. J. M., Plemel, Jason R., Geurts, Jeroen J. G., Schenk, Geert J.
Publicado 2021

Natalizumab concentrations during pregnancy in three patients with multiple sclerosis

por Toorop, Alyssa A, Rispens, Theo, Strijbis, Eva MM, van Oosten, Bob W, de Jong, Brigit A, Uitdehaag, Bernard MJ, Killestein, Joep, van Kempen, Zoé LE
Publicado 2021

Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset

por Koch, Marcus W, Moral, Ester, Brieva, Luis, Mostert, Jop, Strijbis, Eva MM, Comtois, Jacynthe, Repovic, Pavle, Bowen, James D, Wolinsky, Jerry S, Lublin, Fred D, Cutter, Gary
Publicado 2023

Resting-state MEG measurement of functional activation as a biomarker for cognitive decline in MS

por Schoonhoven, Deborah N, Fraschini, Matteo, Tewarie, Prejaas, Uitdehaag, Bernard MJ, Eijlers, Anand JC, Geurts, Jeroen JG, Hillebrand, Arjan, Schoonheim, Menno M, Stam, Cornelis J, Strijbis, Eva MM
Publicado 2018

State Changes During Resting-State (Magneto)encephalographic Studies: The Effect of Drowsiness on Spectral, Connectivity, and Network Analyses

por Strijbis, Eva M. M., Timar, Yannick S. S., Schoonhoven, Deborah N., Nauta, Ilse M., Kulik, Shanna D., de Ruiter, Lodewijk R. J., Schoonheim, Menno M., Hillebrand, Arjan, Stam, Cornelis J.
Publicado 2022

Adipokines in multiple sclerosis patients are related to clinical and radiological measures

por Loonstra, Floor C., Falize, Kim F., de Ruiter, Lodewijk R. J., Schoonheim, Menno M., Strijbis, Eva M. M., Killestein, Joep, de Vries, Helga E., Uitdehaag, Bernard M. J., Rijnsburger, Merel
Publicado 2022

Neurophysiological MEG markers of cognitive impairment and performance validity in multiple sclerosis

por Simon, Shira, Nauta, Ilse M, Hillebrand, Arjan, Schoonheim, Menno M, Uitdehaag, Bernard MJ, van Dam, Maureen, Hulst, Hanneke E, Klein, Martin, Stam, Cornelis J, de Jong, Brigit A, Strijbis, Eva MM
Publicado 2023

Blood platelet RNA enables the detection of multiple sclerosis

por Sol, Nik, Leurs, Cyra E, Veld, Sjors GJG In ’t, Strijbis, Eva M, Vancura, Adrienne, Schweiger, Markus W, Teunissen, Charlotte E, Mateen, Farrah J, Tannous, Bakhos A, Best, Myron G, Würdinger, Thomas, Killestein, Joep
Publicado 2020

Neuroaxonal and Glial Markers in Patients of the Same Age With Multiple Sclerosis

por Loonstra, Floor C., de Ruiter, Lodewijk R.J., Koel-Simmelink, Marleen J.A., Schoonheim, Menno M., Strijbis, Eva M.M., Moraal, Bastiaan, Barkhof, Frederik, Uitdehaag, Bernard M.J., Teunissen, Charlotte, Killestein, Joep
Publicado 2022

Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab

por Toorop, Alyssa A., van Lierop, Zoë Y.G., Strijbis, Eva E.M., Teunissen, Charlotte E., Petzold, Axel, Wattjes, Mike P., Barkhof, Frederik, de Jong, Brigit A., van Kempen, Zoé L.E., Killestein, Joep
Publicado 2020